Latest Strategic Initiatives News

Sports Entertainment Group reports a robust first half FY26 with nearly doubling EBITDA and declares special dividends following asset sales.

IDT Australia Limited has reported a significant narrowing of its half-year loss to $1.3 million, driven by stable revenues and operational efficiencies. The pharmaceutical manufacturer highlights growth in key segments despite some timing setbacks.

QEM Limited has raised $1.442 million through a well-supported placement to fund a strategic review of its flagship Julia Creek Vanadium and Energy Project and explore new critical minerals opportunities.

The Lottery Corporation has reported a resilient half-year performance despite the lowest jackpot outcomes since its demerger, maintaining dividends and growing its digital footprint.

Dexus has announced a new on-market buyback of up to 10% of its securities, aiming to address the disconnect between its market valuation and underlying asset values while maintaining capital discipline.

Dexus has reported a strong half-year result with a $348.5 million profit turnaround, robust leasing growth, and strategic capital moves including a $950 million equity raise and a 10% on-market buyback.

Step One Clothing reports a sharp revenue decline and a significant inventory write-down, posting a net loss in the first half of 2026. The company signals a strategic reset to regain momentum.

Austral Gold has raised A$8.456 million through a strategic placement aimed at accelerating exploration and expanding processing capacity in its key South American assets.

Australian Bond Exchange Holdings has completed a $982,071 private placement, attracting new international and domestic investors to support its growth strategy.

The Takeovers Panel has intervened to adjourn Humm Group's shareholder meeting amid ongoing disputes, extending the timeline for key decisions.

Magnetite Mines’ Razorback Iron Ore Project has been granted Major Project Status by the Australian Government, recognising its national economic importance and unlocking enhanced regulatory support for the next three years.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.